Raghav Ramdev News Today

Goldman Sachs invests in Aragen Life Sciences (GVK Bio) May 20, 2021 The company has invested more than $3.6 billion in capital since 2006 Goldman Sachs has acquired a significant minority stake in Aragen Life Sciences (Aragen), formerly known as GVK Biosciences, by acquiring shares previously held by ChrysCapital and other existing shareholders. Aragen is a leading provider of outsourced discovery, development, and manufacturing services across both large and small molecule platforms. Promote...

Synopsis Aragen is a leading provider of outsourced discovery, development, and manufacturing services across both large and small molecule platforms. The company serves a worldwide customer base which spans to the United States, Europe, and Japan. Wall Street behemoth Goldman Sachs has taken a significant minority stake in Aragen Life Sciences, formerly known as GVK Biosciences, a leading contract research organization (CRO), the company announced today. Goldman Sachs, an active investor in I...

Goldman Sachs Invests in Aragen Life Sciences Wednesday, May 19, 2021 11:55AM IST (6:25AM GMT)   Hyderabad, India:  Aragen Life Sciences (“Aragen”), formerly known as GVK Biosciences and a leading contract research organization (CRO), announced today that Goldman Sachs, an active investor in India, has taken a significant minority stake in the company by acquiring shares previously held by ChrysCapital and other existing sharehol...